DelveInsight’s “Immune Thrombocytopenic Purpura – Epidemiology Forecast to 2032“ report delivers an in-depth understanding of the disease, historical and forecasted Immune Thrombocytopenic Purpura epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Some of the key facts of the ImmuneThrombocytopenia Market Report:
Key benefits of the Immune Thrombocytopenia Purpura Market report:
Got queries? Click here to know more about the ImmuneThrombocytopeniaPurpura Market Landscape
ImmuneThrombocytopenia PurpuraOverview
Immune thrombocytopenia (ITP), previously called immune thrombocytopenic purpura or idiopathic thrombocytopenic purpura, is an autoimmune disorder that occurs when the body attacks its own platelets and destroys them too quickly. ITP was previously called as, idiopathic thrombocytopenic purpura:Idiopathic: The cause is unknown. Thrombocytopenia: A decreased number of platelets in the blood.Purpura: Refers to the purple discoloration of the skin, as with a bruise. The word “immune” more accurately describes that ITP is an immunologic disease, where the body destroys its own platelets. However, although not all aspects of the pathogenesis of ITP are understood, the disease can no longer be considered idiopathic. In addition, many patients do not have purpura at the time of diagnosis.
ITP is now defined as a quantitative decrease in platelet count related to any immune process. When there is no secondary disease, it is known as primary ITP which accounts for 80% of cases. Common causes of secondary ITP are systemic lupus erythematosus (SLE), drugs, Hepatitis C, human immunodeficiency virus (HIV), Helicobacter Pylori, Chronic Lymphocytic Leukemia, and other lymphoproliferative diseases, the antiphospholipid Syndrome, vaccines (Measles/Mumps/Rubella [MMR] most commonly), and Common Variable Immunodeficiency Disease (CVID) as well as other viruses, post-transfusion purpura, and Evans syndrome. These secondary causes account for approximately 20% of cases of ITP. The treatment strategies consist in stimulating platelet production to increase the platelet counts, increasing platelet half-life, and decreasing the auto-reactive nature of the immune response by targeting the auto-reactive antibody production and platelet destruction. Further investigations are, however, still needed to better understand the transition toward chronicity and its implication for the treatment response, outcome, and cure for ITP.
ImmuneThrombocytopenia Purpurea Market Epidemiological Insight
Immune Thrombocytopenia Purpurea Epidemiological Segmentation
Immune Thrombocytopenia Purpurea Market Outlook
The Immune Thrombocytopenia Purpurea market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers, and demand for better technology.
This segment gives a thorough detail of the market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Melanoma market in 7MM is expected to witness a major change in the study period 2019-2032.
Learn more by requesting for sample @Immuno Thrombocytopenia Purpura Market Landscape
Immune Thrombocytopenia Key Companies
Immune Thrombocytopenia Therapies
Table of Contents
Click here to read more about Immune Thrombocytopenia Purpura Market
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Adya KaulEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/